Feds Reclassify Medical Marijuana: What It Means for THCa in 2026

TL;DR: The federal government moved marijuana reclassification forward in April 2026, but what happened is more complicated than the headlines suggest. Two separate legal clocks are now running at once, and both directly affect THCa.

• Acting AG Todd Blanche signed the marijuana reclassification order on April 22, 2026, moving state-licensed medical marijuana to Schedule III
• The signing did not legalize recreational cannabis or protect unlicensed hemp operators
• A DEA hearing on full marijuana rescheduling began June 29, 2026, but no final date exists
• H.R. 5371 redefines hemp using total THC, pulling most THCa products out of legal hemp status starting November 12, 2026
• Two federal timelines now run simultaneously, and THCa sellers and consumers need to track both

There's more going on here than most headlines let on. The feds made a historic move in April 2026, and the hemp world took notice. Two separate legal clocks now run simultaneously, and both affect THCa directly. If you buy or sell THCa, you need to know what's coming before November arrives.

What Just Happened with Marijuana Reclassification?

On April 22, 2026, Acting Attorney General Todd Blanche signed the marijuana reclassification order. That order placed FDA-approved cannabis products and state-licensed medical marijuana into Schedule III of the Controlled Substances Act. The DOJ published the final order in the Federal Register on April 28, 2026. No drawn-out rulemaking process — Blanche signed it and it took force.

This marijuana reclassification signing did not legalize recreational cannabis. It also did not cover unlicensed hemp operators selling outside a qualifying state medical program. Schedule I basically meant the feds considered marijuana dangerous with zero medical value. Schedule III means they finally recognize it has legitimate medical use, and that's a significant shift.

What Does Marijuana Reclassification Schedule 3 Change?

Marijuana reclassification schedule 3 delivers real, immediate changes for licensed medical operators across the country. State-licensed medical cannabis businesses no longer face the Section 280E tax burden that had blocked normal business deductions. That tax created serious financial strain for qualifying operators for years. Those businesses can now register directly with the DEA as manufacturers, distributors, or dispensers.

Scientists can now actually study marijuana without fighting federal red tape at every turn. That matters because the knowledge gap between what patients experience and what research confirms has been wide for a long time. President Trump's December 18, 2025 Executive Order directed the Attorney General to push rescheduling forward. The goal was to close that gap on patient safety and treatment efficacy.

The Marijuana Reclassification Update on Broader Cannabis

The April 22 order covered only state-licensed medical marijuana and FDA-approved products. A formal DEA administrative hearing on broader rescheduling began June 29, 2026.

This marijuana reclassification update shows regulators moving in two stages, not all at once. Licensed medical programs moved into Schedule III immediately. A formal legal process now evaluates full rescheduling for all remaining cannabis under the law.

The hearing opens the process to public comment, expert testimony, and full agency review. Full rescheduling of all marijuana to Schedule III is not yet finalized. Recreational cannabis and unlicensed operators still remain under Schedule I for now.

When Will Marijuana Reclassification Take Effect for All Cannabis?

Many people want to know: when will marijuana reclassification take effect beyond licensed medical programs? The answer depends entirely on the outcome of the ongoing DEA hearing process. That process includes expert testimony, agency review, and a complete final rulemaking cycle. Nobody has a finish line yet — this process could take months.

No confirmed date exists yet for broader rescheduling of all marijuana under the law. The hearing opened June 29, 2026, but a final rule still needs full administrative review. Federal Register publication must come after that review before a new rule takes nationwide legal effect. All non-medical cannabis stays in Schedule I until that final rule formally arrives.

What Does Marijuana Reclassification Mean for THCa?

So, what does marijuana reclassification mean for the hemp-derived THCa market specifically? The April rescheduling order does not protect THCa products sold under the 2018 Farm Bill framework. THCa occupied a legal gray zone based on pre-decarboxylation delta-9 THC levels. Congress shut that door in November 2025 by rewriting the definition of hemp.

H.R. 5371 became law on November 12, 2025, and redefined hemp using a total THC standard. That law explicitly includes THCA in the total THC calculation. Products exceeding 0.3% total THC on a dry-weight basis become federally classified as marijuana. That standard takes full enforcement effect on November 12, 2026.

Two Federal Clocks Running Simultaneously

Here's the thing — two completely different federal clocks are ticking right now. The DEA hearing that began June 29, 2026 could eventually extend Schedule III status to all marijuana. The November 12, 2026 hemp deadline removes most high-THCa products from legal hemp status regardless of that hearing's result.

In states without licensed marijuana programs, November 2026 ends the legal sale of most THCa flower. In states with licensed medical or adult-use programs, those products may shift into regulated cannabis channels. The DEA website and the Federal Register remain the most reliable places to track what federal law does next. In the meantime, browse Smoke Kind's current THCa selection and stock up before the landscape shifts.